Search results
Cevira Phase III trial for non-surgical HSIL treatment meets primary endpoint
Investing.com via Yahoo Singapore Finance· 9 months agoPhotocure ASA (OSE: PHO) and its partner Asieris Pharmaceuticals (SSE (LON:SSE): 688176) announced on Wednesday that their multinational Phase III clinical trial for Cevira (APL-1702) has successfully ...